Showing 661-670 of 2783 results for "".
Catamenial Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/catamenial-epilepsy/31944/Understanding the underlying hormone pathophysiology and types of catamenial epilepsy is necessary for determining treatment options.Cannabinoids and the Endocannabinoid System: Emerging Trends
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-the-endocannabinoid-system-emerging-trends/30406/Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Maintaining Ambulation
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/maintaining-ambulation/30126/Physical therapy, exercise, physical activity, and medications adapted to individual needs can all help maintain the ability to walk.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.Management of Poststroke Mobility and Spasticity
https://practicalneurology.com/diseases-diagnoses/stroke/management-of-poststroke-mobility-and-spasticity/32187/Mobility and spasticity management tailored appropriately to the individual’s needs and abilities, as well as early rehabilitation, result in reduced disability levels and optimized outcomes after stroke.Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-making-progress-for-more-accurate-diagnoses-and-targeted-treatments/32114/Advances in testing and treatments for myasthenia gravis are leading to more accurate diagnoses and improvements in symptom control for individuals with this rare chronic autoimmune disease.